| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/02/2008 | EP1937084A2 Use of fructanases in feed of hoofed animals to treat and prevent laminitis |
| 07/02/2008 | EP1539166B1 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| 07/02/2008 | EP1533313B1 Novel flavone c-glycoside derivatives and composition containing the derivatives |
| 07/02/2008 | EP1501808B1 Tachykinin receptor antagonists |
| 07/02/2008 | EP1474425B9 Deazapurines and uses thereof |
| 07/02/2008 | EP1459762B1 Use of emp9 for the prevention of proliferative organ diseases |
| 07/02/2008 | EP1339749B1 Methods for producing improved dextran-hemoglobin conjugates |
| 07/02/2008 | EP1296940B1 Amidine derivatives as selective antagonists of nmda receptors |
| 07/02/2008 | EP1141003B9 Methods of activation of SGK by phosphorylation. |
| 07/02/2008 | EP1119349B1 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 07/02/2008 | EP1115720B1 Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 07/02/2008 | CN101213178A Benzenoid ansamycin derivative |
| 07/02/2008 | CN101210051A Anti-VEGF antibodies |
| 07/02/2008 | CN101210050A Anti-vegf antibodies |
| 07/02/2008 | CN101209269A Application of oligose in soft extract |
| 07/02/2008 | CN101209088A Microorganism polyzyme additive agent for improving pigling growth and development |
| 07/02/2008 | CN100398661C Casein hydrolyzate, process for producing the same and use thereof |
| 07/02/2008 | CN100398551C Novel isoforms of vascular endothelial cell growth inhibitor |
| 07/02/2008 | CN100398541C Pyrimidinone derivatives and 3-keto ester |
| 07/02/2008 | CN100398535C Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5 |
| 07/02/2008 | CN100398153C Combined pharmaceutical application of antiangiogenic drugs and photosensitizers |
| 07/02/2008 | CN100398146C Use of composition in preparation of medicament for spirit raising and brain arousing with no habituction |
| 07/02/2008 | CN100398138C Chinese medicine for against depressive disorders and hypothermia |
| 07/02/2008 | CN100398113C Nano selenium of Melatonin and its preparation method |
| 07/02/2008 | CN100398106C Use of nk-1 receptor antagonists against benign prostatic hyperplasia |
| 07/02/2008 | CN100398103C Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 07/02/2008 | CN100398094C Formoterol superfine formulation |
| 07/01/2008 | USRE40418 Treatment of neoplasms with CCI-779/EKB-569 combination |
| 07/01/2008 | US7393953 Polymeric acyl derivatives of indoles |
| 07/01/2008 | US7393942 Nucleic acids encoding mutant forms of Fas ligand |
| 07/01/2008 | US7393937 N-acetylglucosamine derivatives and use thereof |
| 07/01/2008 | US7393929 Inhibitors of cellulolytic, xylanolytic and β-glucanolytic enzymes |
| 07/01/2008 | US7393872 Sodium channel blocker compositions and the use thereof |
| 07/01/2008 | US7393859 Amide substituted imidazoquinolines |
| 07/01/2008 | US7393850 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 07/01/2008 | US7393849 N-[4-Amidinobenzoyl]-N-[3-phenoxybenzyl]-3-(4-biphenyl)-alanyl-glycyl-amide; anticarcinogenic, antidiabetic, anticholesterol agent, cardiovascular disorders, osteoporosis |
| 07/01/2008 | US7393845 2-{2-[4-(2,3-Dihydrobenzo[1,4]dioxin-5-yl)piperazin-1-yl]ethylsulfanyl}-6-methylnicotinonitrile; serotonin and dopamine receptor antagonist, serotonin reuptake inhibitor; anxiolytic agent, antidepressant; panic and obsessive compulsive disorder, social phobia, eating disorders, psychosis |
| 07/01/2008 | US7393842 Pyrazole analogs acting on cannabinoid receptors |
| 07/01/2008 | US7393838 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 07/01/2008 | US7393825 Restoring balance in vascular tone without systemic effect in normal vasculature; administration of minimal amounts of nitric oxide donors and/or guanyl cyclase activators |
| 07/01/2008 | US7393655 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder |
| 07/01/2008 | US7393545 Lipstatin derivative—soluble fiber tablets |
| 07/01/2008 | US7393526 Systemic gene delivery vehicles for the treatment of tumors |
| 06/26/2008 | WO2008075997A1 Method for treating opioid withdrawal syndrome |
| 06/26/2008 | WO2008075957A1 Treatment of fabry disease |
| 06/26/2008 | WO2008074267A2 Liposomal gel phthalocyanine preparation for photodynamic therapy of tumors and its manufacturing |
| 06/26/2008 | WO2008074091A1 Radioprotector compounds and related methods |
| 06/26/2008 | WO2008057930A3 Methods of treating neuropathic pain with retinoic acid receptor agonists |
| 06/26/2008 | WO2008041514A9 Radiation sensitizer or anti-cancer chemotherapy sensitizer |
| 06/26/2008 | WO2008016378A3 Methods to treat and/or prevent radiation- and/or chemical-induced toxicity in non-malignant tissue |
| 06/26/2008 | WO2008009639A3 New indications for direct thrombin inhibitors |
| 06/26/2008 | WO2007137260A3 Preparation of polymer conjugates of vla-4 antagonists via a mitsunobu' s reaction |
| 06/26/2008 | US20080153920 Administration of nitric oxide donor with insufflation gas; increasing fetal cerebral oxygenation during laparoscopic procedure |
| 06/26/2008 | US20080153918 treatment of sleep disorders and related diseases, with five novel polymorphic forms of modafinil racemate called CRL 40476 form III, CRL 40476 form IV, CRL 40476 form V, CRL 40476 form VI, CRL 40476 form VII; preparing a new solvate of modafinil comprising dissolving in solvent and crystallizing |
| 06/26/2008 | US20080153899 Fatty amine drug conjugates |
| 06/26/2008 | US20080153898 Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use |
| 06/26/2008 | US20080153871 Antagonists of the trpv1 receptor and uses thereof |
| 06/26/2008 | US20080153866 Amorphous Taclolimus Solid Dispersion Having an Enhanced Solubility and Pharmaceutical Composition Comprising Same |
| 06/26/2008 | US20080153864 Spiroazabicyclic Heterocyclic Compounds |
| 06/26/2008 | US20080153857 Specific capsaicin receptor modulators; analgesics; neuropathic pain; obesity; antitussives, hiccups; e.g. (4-Cyclopropyl-phenyl)-[2-methoxymethyl-7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-4-yl]-amine |
| 06/26/2008 | US20080153855 Chemical Compounds |
| 06/26/2008 | US20080153852 Tryptophan hydroxylase inhibitors; anticarcinogenic agents; gastrointestinal, cardiovascular, and respiratory system disorders |
| 06/26/2008 | US20080153835 Therapeutic agents useful for treating pain |
| 06/26/2008 | US20080153823 a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy |
| 06/26/2008 | US20080153822 Methods of treating pain |
| 06/26/2008 | US20080153821 Nitrogen-containing 5-membered ring compound |
| 06/26/2008 | US20080153809 Novel amides useful for treating pain |
| 06/26/2008 | US20080153798 Methods of inhibiting nitric oxide synthase using corrin derivatives |
| 06/26/2008 | US20080153789 Testosterone analog or gonadotrophin releasing hormone analog in a topical carrier; micro or nanoparticles; disorders of the subcutaneous fatty tissue |
| 06/26/2008 | US20080153779 Comprising an active agent, a delivery agent compound, and at least one of a swellable polymer (polyethylene oxide), a release controlling polymer (polyacrylic acid), or a mucoadhesive |
| 06/26/2008 | US20080153766 Non-insulin dependent diabetes mellitus; lowers hepatic fatty degeneration; improving liver function by reducing alanine transaminase and aspartate transaminase levels |
| 06/26/2008 | US20080153764 Used in cells and transgenic animals for a variety of applications including producing and studying the effects of RNAi and microRNA mediated gene silencing. |
| 06/26/2008 | US20080153753 Method of treating side effects induced by therapeutic agents |
| 06/26/2008 | US20080153751 Albumin Fusion Proteins |
| 06/26/2008 | US20080153749 Methods and compositions for cell-cycle regulation |
| 06/26/2008 | US20080153742 Fas peptide mimetics and uses thereof |
| 06/26/2008 | US20080153107 Isolated PGE synthase, provided from encoding nucleic acid. Methods of production and use. Assays for modulators, especially inhibitors, of PGE synthase activity. |
| 06/26/2008 | US20080152731 Compositions and method for hair loss prevention |
| 06/26/2008 | US20080152726 Using polyunsaturated fatty acid and agent which adjust methionine metabolism such as vitamin b6, b12, folic acid; Parkinson's and Huntington's disease; antiepileptic agents; schizophrenia; antiepileptic agents; sleep disorders; antidepressants |
| 06/26/2008 | US20080152695 Oral/buccal transmucosal delivery methods for electrolyte compositions including xylitol |
| 06/26/2008 | US20080152689 Devices containing dna encoding neurotrophic agents and related compositions and methods |
| 06/26/2008 | US20080152672 Methods for treating gluteal muscle |
| 06/26/2008 | US20080152656 Using kallikren specific inhibitor as therapeutic tool in treating cardiocascular disorders; treating soft tissue and bone trauma; tissue repair |
| 06/26/2008 | US20080152651 Beta-like glycoprotein hormone polypeptide specific immunoglobulin for treatment of autoimmune, inflammatory, (such as rheumatoid arthritis, psoriasis, multiple sclerosis, toxic shock, bone marrow and organ transplantation disorders |
| 06/26/2008 | US20080152632 Promoter-reporter cells for determining drug metabolism, drug interactions, and the effects of allotype variation |
| 06/26/2008 | US20080152630 Method of generation and expansion of tissue-progenitor cells and mature tissue cells from intact bone marrow or intact umbilical cord tissue |
| 06/26/2008 | US20080152625 Swine Population Having Low Levels of Porcine Endogenous Retrovirus and Uses Thereof |
| 06/26/2008 | US20080152590 Engraftable Neural Progenitor and Stem Cells for Brain Tumor Therapy |
| 06/26/2008 | US20080152586 Protein complexes comprising three or more polypeptides, each having multiple immunoglobulin like domains, which associate to form target binding regions, for use as therapeutic, diagnostic or imaging agents |
| 06/26/2008 | US20080149097 Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disordersB |
| 06/26/2008 | CA2673417A1 Radioprotective benzimidazole compounds and related methods |
| 06/26/2008 | CA2665762A1 Liposomal gel phthalocyanine preparation for photodynamic therapy of tumors and its manufacturing |
| 06/25/2008 | EP1935890A1 2-heteroaryl-substituted indole derivative |
| 06/25/2008 | EP1935885A2 Melanin concentrating hormone receptor ligands : substituted 1-benzyl-4-aryl piperazine analogues. |
| 06/25/2008 | EP1935882A1 Bicyclic compounds |
| 06/25/2008 | EP1935879A1 Substituted cycloalkene derivative |
| 06/25/2008 | EP1935874A1 S1p3 receptor antagonist |
| 06/25/2008 | EP1935869A1 Retinoids for the treatment of emphysema |
| 06/25/2008 | EP1935432A1 Medical agent containing insulin resistance improving agent |
| 06/25/2008 | EP1935431A2 Cancer treatments by using a combination of an antibody against her2 and interleukin-2 |